Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2015, Article ID 424813, 8 pages
http://dx.doi.org/10.1155/2015/424813
Research Article

Effect of Metformin and Sitagliptin on Doxorubicin-Induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation, and Apoptosis

Department of Pharmacology, Faculty of Medicine, Minia University, Minia, Egypt

Received 27 October 2015; Accepted 14 December 2015

Academic Editor: Lucio Guido Costa

Copyright © 2015 Mina Thabet Kelleni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. C. Simbre II, S. A. Duffy, G. H. Dadlani, T. L. Miller, and S. E. Lipshultz, “Cardiotoxicity of cancer chemotherapy: implications for children,” Pediatric Drugs, vol. 7, no. 3, pp. 187–202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Oktem, S. Ayla, I. Seckin et al., “Doxorubicin induced nephrotoxicity: protective effect of nicotinamide,” International Journal of Cell Biology, vol. 2011, Article ID 390238, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. K. Shakir and K. I. Rasul, “Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management,” Journal of Clinical Medicine Research, vol. 1, no. 1, pp. 8–12, 2009. View at Publisher · View at Google Scholar
  4. T. Šimůnek, M. Štěrba, O. Popelová, M. Adamcová, R. Hrdina, and V. Gerši, “Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron,” Pharmacological Reports, vol. 61, no. 1, pp. 154–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Goormaghtigh, P. Huart, M. Praet, R. Brasseur, and J. M. Ruysschaert, “Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity,” Biophysical Chemistry, vol. 35, no. 2-3, pp. 247–257, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. S. V. Kalivendi, E. A. Konorev, S. Cunningham et al., “Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium,” The Biochemical Journal, vol. 389, no. 2, pp. 527–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Martin-Montalvo, E. M. Mercken, S. J. Mitchell et al., “Metformin improves healthspan and lifespan in mice,” Nature Communications, vol. 4, article 3192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. R. White Jr., “Dipeptidyl peptidase-IV inhibitors: pharmacological profile and clinical use,” Clinical Diabetes, vol. 26, no. 2, pp. 53–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Padrutt, T. A. Lutz, C. E. Reusch, and E. Zini, “Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats,” Research in Veterinary Science, vol. 99, pp. 23–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Vaghasiya, N. Sheth, Y. Bhalodia, and R. Manek, “Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes,” Regulatory Peptides, vol. 166, no. 1–3, pp. 48–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Makdissi, H. Ghanim, M. Vora et al., “Sitagliptin exerts an antinflammatory action,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. 3333–3341, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. N. Buhl and K. Y. Jackson, “Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C,” Clinical Chemistry, vol. 24, no. 5, pp. 828–831, 1978. View at Google Scholar
  13. A. H. B. Wu and G. N. Bowers Jr., “Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals,” Clinical Chemistry, vol. 28, no. 10, pp. 2017–2021, 1982. View at Google Scholar · View at Scopus
  14. J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology, vol. 52, pp. 302–310, 1978. View at Publisher · View at Google Scholar
  15. Ü. Mutlu-Türkoðlu, Z. Akalin, E. Ilhan et al., “Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease,” Clinical Biochemistry, vol. 38, no. 12, pp. 1059–1065, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. V. H. Sastry, R. P. Moudgal, J. Mohan, J. S. Tyagi, and G. S. Rao, “Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy,” Analytical Biochemistry, vol. 306, no. 1, pp. 79–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Marklund and G. Marklund, “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,” European Journal of Biochemistry, vol. 47, no. 3, pp. 469–474, 1974. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Ibrahim, O. M. Ashour, Y. F. Ibrahim, H. I. EL-Bitar, W. Gomaa, and S. R. Abdel-Rahim, “Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity,” Pharmacological Research, vol. 60, no. 5, pp. 373–381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-Y. Sun, F.-S. Xue, Y.-C. Xu et al., “Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts,” Chinese Medical Journal, vol. 122, no. 24, pp. 3048–3054, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. I. M. Kafa, M. Uysal, S. Bakirci, and A. Kurt, “Sepsis induces apoptotic cell death in different regions of the brain in a rat model of sepsis,” Acta Neurobiologiae Experimentalis, vol. 70, no. 3, pp. 246–260, 2010. View at Google Scholar · View at Scopus
  21. K. Shan, A. M. Lincoff, and J. B. Young, “Anthracycline-induced cardiotoxicity,” Annals of Internal Medicine, vol. 125, no. 1, pp. 47–58, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. P. K. Singal and N. Iliskovic, “Doxorubicin-induced cardiomyopathy,” The New England Journal of Medicine, vol. 339, no. 13, pp. 900–905, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Ichikawa, M. Ghanefar, M. Bayeva et al., “Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation,” The Journal of Clinical Investigation, vol. 124, no. 2, pp. 617–630, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. O. A. Al-Shabanah, A. M. Aleisa, M. M. Hafez et al., “Desferrioxamine attenuates doxorubicin-induced acute cardiotoxicity through TFG-β/Smad p53 pathway in rat model,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 619185, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-C. Yen, T. D. Oberley, S. Vichitbandha, Y.-S. Ho, and D. K. St Clair, “The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice,” The Journal of Clinical Investigation, vol. 98, no. 5, pp. 1253–1260, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Hadi, N. G. Yousif, F. G. Al-Amran, N. K. Huntei, B. I. Mohammad, and S. J. Ali, “Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response,” BMC Cardiovascular Disorders, vol. 12, article 63, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Chang, P. Zhang, L. Ye et al., “Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model,” European Journal of Pharmacology, vol. 718, no. 1–3, pp. 105–113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. E. Ashour, M. M. Sayed-Ahmed, A. R. Abd-Allah et al., “Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 434195, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Aleisa, S. S. Al-Rejaie, S. A. Bakheet et al., “Effect of metformin on clastogenic and biochemical changes induced by adriamycin in Swiss albino mice,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 634, no. 1-2, pp. 93–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Nader, “Sitagliptin ameliorates lipid profile changes and endothelium dysfunction induced by atherogenic diet in rabbits,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 387, no. 5, pp. 433–444, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Jayakumar, K. V. Pugalendi, and M. Sankaran, “Attenuation of hyperglycemia-mediated oxidative stress by indole-3-carbinol and its metabolite 3, 3′-diindolylmethane in C57BL/6J mice,” Journal of Physiology and Biochemistry, vol. 70, no. 2, pp. 525–534, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S. S. Ramesh, A. Prasanthi, D. I. Bhat, B. I. Devi, R. Cristopher, and M. Philip, “Correlation between plasma total nitric oxide levels and cerebral vasospasm and clinical outcome in patients with aneurysmal subarachnoid hemorrhage in Indian population,” Journal of Neurosciences in Rural Practice, vol. 5, supplement 1, pp. S22–S27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. C.-X. Zhang, S.-N. Pan, R.-S. Meng et al., “Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 1, pp. 55–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Xie, S.-D. Zhang, X.-P. Ou, and T.-L. Yang, “Protective effects of metformin on low-density lipoprotein-induced endothelial dysfunction in rats,” Journal of Southern Medical University, vol. 29, no. 5, pp. 890–893, 2009. View at Google Scholar · View at Scopus
  35. N. M. Kalariya, M. Shoeb, N. H. Ansari, S. K. Srivastava, and K. V. Ramana, “Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats,” Investigative Ophthalmology & Visual Science, vol. 53, no. 7, pp. 3431–3440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. E. M. Elia, R. Quintana, C. Carrere et al., “Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study,” Journal of Ovarian Research, vol. 6, no. 1, article 62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. C. Asensio-Lopez, J. Sanchez-Mas, D. A. Pascual-Figal, C. de Torre, M. Valdes, and A. Lax, “Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes,” Free Radical Biology & Medicine, vol. 67, pp. 19–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Liu, J. Liu, X. Y. Tian et al., “Uncoupling protein-2 mediates DPP-4 Inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress,” Antioxidants & Redox Signaling, vol. 21, no. 11, pp. 1571–1581, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. A. Nader, M. S. El-Awady, A. A. Shalaby, and D. S. El-Agamy, “Sitagliptin exerts anti-inflammatory and anti-allergic effects in ovalbumin-induced murine model of allergic airway disease,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 385, no. 9, pp. 909–919, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. E. El-Sahar, M. M. Safar, H. F. Zaki, A. S. Attia, and A. A. Ain-Shoka, “Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway,” Life Sciences, vol. 126, pp. 81–86, 2015. View at Publisher · View at Google Scholar